Biocon Ltd. | BIOCON | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
6,881
4,531
10,026
8,709
8,462
Cash flow Operating Act...
Cash flow Operating Activities
6,4006,62111,54612,83111,597
Investments in PPE
Investments in PPE
-6,084-7,382-12,221-16,042-17,463
Cash flow Investing Act...
Net cash used for Investment Activities
-4,985-6,840-7,138-15,589-36,247
Dividend Paid
Dividend Paid
07877937010
Cash flow Financing Act...
Net cash provided by Financing Activities
-1,775-2,397-2,4173,87625,640
Cash at beginning of period
Cash at beginning of period
7,5757,1024,4906,5938,247
Cash at end of period
Cash at end of period
7,1024,4906,5938,2478,970
Free Cash Flow
Free Cash Flow
316
-761
-675
-3,211
-5,866